We are live on ! Find out more

Small Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
RAPP icon
26
Rapport Therapeutics
RAPP
$1.55B
$1.55B $26.15 1.16%
IMCR icon
27
Immunocore
IMCR
$1.55B
$1.55B $29.94 1.77%
ABSI icon
28
Absci
ABSI
$1.46B
$1.46B $8.45 7.55%
KRSA icon
29
Korsana Biosciences, Inc. Common Stock
KRSA
$1.44B
$1.44B $31.65 1.18%
GPCR icon
30
Structure Therapeutics
GPCR
$1.43B
$1.43B $20 0.81%
NUVB icon
31
Nuvation Bio
NUVB
$1.41B
$1.41B $3.99 1.72%
NVAX icon
32
Novavax
NVAX
$1.41B
$1.41B $8.53 2.63%
LBRX icon
33
LB Pharmaceuticals
LBRX
$1.39B
$1.39B $43.01 1.3%
TYRA icon
34
Tyra Biosciences
TYRA
$1.38B
$1.38B $20.02 1.26%
ANAB icon
35
AnaptysBio
ANAB
$1.38B
$1.38B $46.25 3.18%
OCUL icon
36
Ocular Therapeutix
OCUL
$1.37B
$1.37B $6.21 1.11%
AAPG icon
37
Ascentage Pharma
AAPG
$1.37B
$1.37B $14.62 2.66%
NTLA icon
38
Intellia Therapeutics
NTLA
$1.36B
$1.36B $9.70 8.06%
MLYS icon
39
Mineralys Therapeutics
MLYS
$1.36B
$1.36B $15.33 1.1%
INVA icon
40
Innoviva
INVA
$1.35B
$1.35B $19.03 0.32%
AVLN icon
41
Avalyn Pharma
AVLN
$1.35B
$1.35B $30.28 1.01%
DMRA icon
42
Damora Therapeutics
DMRA
$1.34B
$1.34B $21.60 2.04%
TSHA icon
43
Taysha Gene Therapies
TSHA
$1.34B
$1.34B $4.10 2.61%
MNKD icon
44
MannKind Corp
MNKD
$1.33B
$1.33B $4.13 0.72%
GHRS icon
45
GH Research
GHRS
$1.31B
$1.31B $19.10 3.3%
KARD
46
Kardigan Inc
KARD
$1.29B
$1.29B $13.82 2.12%
URGN icon
47
UroGen Pharma
URGN
$1.28B
$1.28B $26.18 0.8%
NKTR icon
48
Nektar Therapeutics
NKTR
$1.27B
$1.27B $37.27 0.05%
OMER icon
49
Omeros
OMER
$1.27B
$1.27B $17.49 2.78%
DRTS icon
50
Alpha Tau Medical
DRTS
$1.24B
$1.24B $13.38 0.15%
1
2
3 4 5

Small Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 186 small cap Biotechnology stocks — companies in the Biotechnology industry with a market cap between $250M and $2B — worth a combined $157B.

The largest by market cap are Recursion Pharmaceuticals (RXRX) at $1.99B, Harmony Biosciences (HRMY) at $1.98B and First Tracks Biotherapeutics (TRAX) at $1.98B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 150 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.